IC
ICLR
HealthcareICON Public Limited Company
Diagnostics & Research
Total Trades
5
Unique Traders
4
Purchases / Sales
0/5
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Mar 5, 2026 |  Kevin HernR | Stock | Sell | $100,001 - $250,000 | $110.60 | $114.19 | +3.2% | +6.7% | |
Feb 12, 2026 |  Julia LetlowR | Stock | Sell | $1,001 - $15,000 | $80.08 | $98.33 | +22.8% | +25.6% | |
Jan 29, 2026 |  Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $185.89 | $108.14 | -41.8% | -40.7% | |
Feb 25, 2025 |  Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $197.50 | $180.11 | -8.8% | -4.5% | |
Feb 11, 2025 | Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $187.35 | $178.95 | -4.5% | +4.4% |
Recent News
Citigroup Maintains Neutral on Icon, Lowers Price Target to $120
Benzinga-Invalid Date
Barclays Maintains Equal-Weight on Icon, Lowers Price Target to $120
Benzinga-Invalid Date
ICON shares are trading higher after TD Cowen upgraded the stock from Hold to Buy.
Benzinga-Invalid Date
TD Cowen Upgrades Icon to Buy, Lowers Price Target to $120
Benzinga-Invalid Date
Diamond Hill International Strategy Q4 2025 Portfolio Review
SeekingAlpha-Invalid Date